Found: 2
Select item for more details and to access through your institution.
1003-P: Clinical Response (HbA<sub>1c</sub> ≥1% and/or Body Weight ≥5% Reduction) to Semaglutide by Baseline HbA<sub>1c</sub> and Body Weight in the SUSTAIN Program.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1003-P
- By:
- Publication type:
- Article
Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.
- Published in:
- European Journal of Endocrinology, 2015, v. 173, n. 2, p. 205, doi. 10.1530/EJE-15-0070
- By:
- Publication type:
- Article